
An electron microscopic (EM) image shows mature, oval-shaped monkeypox virus particles as well as crescents and spherical particles of immature virions, obtained from a clinical human skin sample associated with the 2003 prairie dog outbreak in this undated image obtained by Reuters on May 18, 2022.
11:00 JST, May 27, 2022
About 200 confirmed and more than 100 suspected cases of Monkeypox have been detected so far outside of the countries where it usually spreads, a World Health Organization official said on Thursday, urging countries to increase surveillance for the infectious disease.
Monkeypox, a mild viral infection, is endemic in the African countries of Cameroon, Central African Republic, Democratic Republic of Congo, and Nigeria.
The recent outbreak in non-endemic countries has raised concerns. The strain circulating globally is thought to have a fatality rate of around 1%, although effective vaccines and treatments are available.
Talking during an online briefing, WHO’s senior epidemiologist Maria Van Kerkhove said cases have so far been detected in more than 20 non-endemic countries, adding that the agency expected the numbers to go up.
“We expect more cases to be detected. We are asking countries to increase surveillance…This is a containable situation. It will be difficult, but it’s a containable situation in the non-endemic countries.”
Top Articles in News Services
-
Survey Shows False Election Info Perceived as True
-
Japan’s Nikkei Stock Average Falls as US-Iran Tensions Unsettle Investors (UPDATE 1)
-
Japan’s Nikkei Stock Average Rises on Tech Rally and Takaichi’s Spending Hopes (UPDATE 1)
-
Japan to Ban Use of Power Banks on Airplanes
-
North Korea Unveils Image of Kim Jong Un’s Teenage Daughter Firing Rifle
JN ACCESS RANKING
-
Producer Behind Pop Group XG Arrested for Cocaine Possession
-
Japan PM Takaichi’s Cabinet Resigns en Masse
-
Man Infected with Measles Reportedly Dined at Restaurant in Tokyo Station
-
Japan Figure Skating Legend Yuzuru Hanyu Is Proud Disaster Survivor and Gold Medalist, Vows to Continue Support Efforts
-
iPS Treatments Pass Key Milestone, but Broader Applications Far from Guaranteed

